| Kairos Minerals Limited (KAI) ORDINARY FULLY PAID |
Materials |
$68 |
Updated Company Presentation
|
1 May 2025 9:03AM |
$0.020 |
$0.026 |
risen by
30%
|
|
| H&G High Conviction Limited (HCF) ORDINARY FULLY PAID |
Financials |
$1 |
Ceasing to be a substantial holder for HNG
|
1 May 2025 9:03AM |
$0.050 |
$0.027 |
fallen by
46%
|
|
| Hancock & Gore Ltd (HNG) ORDINARY FULLY PAID |
Industrials |
$137 |
Ceasing to be a substantial holder from HCF
|
1 May 2025 9:03AM |
$0.280 |
$0.265 |
fallen by
5.36%
|
|
| H&G High Conviction Limited (HCF) ORDINARY FULLY PAID |
Financials |
$1 |
In-specie distribution and Board changes
|
1 May 2025 9:03AM |
$0.050 |
$0.027 |
fallen by
46%
|
|
| Hancock & Gore Ltd (HNG) ORDINARY FULLY PAID |
Industrials |
$137 |
HCF: In-specie distribution and Board changes
|
1 May 2025 9:03AM |
$0.280 |
$0.265 |
fallen by
5.36%
|
|
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$242 |
Eureka Successfully Upsizes Debt Facility to $185 million
|
1 May 2025 9:02AM |
$0.500 |
$0.570 |
risen by
14%
|
|
EGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Eureka successfully enters into a new upsized $185 million debt facility.
- Provided by National Australia Bank Ltd and Westpac Banking Corporation.
- Facilities spread across 3-, 5- and 7-year periods.
- Material improvement in pricing with competitive interest rate terms.
- Increased future debt capacity with a documented $200 million uncommitted Accordion facility.
- Flexibility provided for capital partnerships and funds.
- Refinanced $101 million of existing debt into a $180 million multilateral facility.
- Includes an annually renewable $5 million working capital facility.
- Financial covenants include a maximum LVR of 55% and ICR greater than 2.0 times.
- CEO Simon Owen expressed optimism regarding the refinancing outcome.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$22 |
Block 3 Gallium Exhibits Highly Favourable Mineralogy
|
1 May 2025 9:01AM |
$0.080 |
$0.091 |
risen by
13.75%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Assessment revealed high-grade gallium mineralization at Block 3.
- CSIRO study confirmed gallium presence in chloritized schists.
- Metallurgical tests will start at Curtin University.
- Drilling set to commence in early May 2025.
- Results will aid in defining a maiden JORC resource.
- Company in talks with strategic partners for development.
- Block 3 project targets high gallium demand due to supply constraints.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Legacy Minerals Holdings Limited (LGM) ORDINARY FULLY PAID |
Materials |
$28 |
Broad and High-Grade Gold in Drilling Intercepts
|
1 May 2025 9:01AM |
$0.240 |
$0.180 |
fallen by
25%
|
|
LGM - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant assay results reported from historic diamond drill core at the Drake Project.
- Notable findings include 95m at 0.9g/t Au and 0.35% Zn.
- High-grade intervals include 10m at 6.0g/t Au from drillhole GT005.
- Continuity of gold mineralization confirmed at the Strauss and Kylo deposits.
- The project remains open in all directions, offering expansion potential.
- Recent Mineral Resource Estimate indicates 0.8Moz of Au and 35Moz of Ag.
- Scoping Study demonstrates robust economics with low operational costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Toys'R'Us ANZ Limited (TOY) ORDINARY FULLY PAID |
Consumer Discretionary |
$4 |
Notification of cessation of securities - TOY
|
1 May 2025 9:00AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
| H&G High Conviction Limited (HCF) ORDINARY FULLY PAID |
Financials |
$1 |
Final Director's Interest Notice - Dennison Hambling
|
1 May 2025 9:00AM |
$0.050 |
$0.027 |
fallen by
46%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$726 |
Net Tangible Asset Backing
|
1 May 2025 8:59AM |
$2.260 |
$2.250 |
fallen by
0.44%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$136 |
Update - Notification of buy-back - VVA
|
1 May 2025 8:59AM |
$1.280 |
$1.340 |
risen by
4.69%
|
|
| Orange Minerals NL (OMX) ORDINARY FULLY PAID |
Materials |
$8 |
Change of Director's Interest Notice - CS
|
1 May 2025 8:59AM |
$0.041 |
$0.059 |
risen by
43.90%
|
|
| DUG Technology Ltd (DUG) ORDINARY FULLY PAID |
Information Technology |
$177 |
FY25-Q3 Business Update
|
1 May 2025 8:59AM |
$1.025 |
$1.315 |
risen by
28.29%
|
|
DUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue in FY25-Q3 was US$16.5 million.
- Software division achieved 23% revenue growth from FY24-Q3.
- EBITDA increased by 15% to US$5.3 million.
- Total cash held at 31 March 2025 was US$16.3 million.
- New Services projects worth US$22.7 million were awarded during the quarter.
- Services Order Book increased by 30% to US$42.7 million.
- Software sales momentum strong among independent oil and gas companies.
- Performance of the HPC business unit continued to be below expectations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$519 |
Procedures Commence at Semmelweis University
|
1 May 2025 8:58AM |
$1.620 |
$1.620 |
fallen by
0%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Semmelweis becomes first hospital in Hungary to perform ablations guided by real-time MRI
- Semmelweis is latest activated site using Imricor’s technology
- First procedures were performed at Semmelweis University’s Heart and Vascular Centre
- Atrial flutter ablations were guided by real-time MRI using Imricor’s platform
- The team at Semmelweis is renowned for its advanced electrophysiology services
- Imricor's Chair and CEO expressed excitement over the expansion into Hungary
- The company anticipates further growth in Europe and the addition of more trial sites
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Race Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$197 |
First Patient Dosed Safely in RC220 Phase 1 Trial
|
1 May 2025 8:57AM |
$1.045 |
$1.135 |
risen by
8.61%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- First patient safely dosed in Phase 1 clinical trial of RC220.
- Trial conducted at Southside Cancer Care Centre, Miranda, NSW.
- No adverse events reported during the initial dosing.
- Trial aims to recruit up to 33 patients across multiple sites.
- Focus on safety, tolerability, and pharmacokinetics of RC220.
- Combination treatment with doxorubicin will be assessed.
- Regular updates on trial progress expected.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Baby Bunting Group Limited (BBN) ORDINARY FULLY PAID |
Consumer Discretionary |
$243 |
Store of the Future and Trading Update
|
1 May 2025 8:56AM |
$1.565 |
$1.800 |
risen by
15.02%
|
|
BBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Comparable store sales growth now at 2.9% (YTD)
- 'Store of the Future' now open in Maribyrnong, Melbourne
- New store format designed to enhance customer experience
- Initial customer feedback on the new store has been positive
- 2H FY25 comparable store sales increased by 3.7%
- Year-to-date gross margin of 40%
- Increased FY25 pro forma NPAT guidance to $10 million to $12.5 million
- FY25 comparable store sales growth expected between 2% to 3%
- Projected capital expenditure of $11 million to $12 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hammer Metals Limited (HMX) ORDINARY FULLY PAID |
Materials |
$31 |
High Ranking Gold Targets to be drilled at Bronzewing South
|
1 May 2025 8:56AM |
$0.028 |
$0.035 |
risen by
25%
|
|
HMX - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade mineralised zone identified at depth on the Bronzewing Mining Lease remains untested within Hammer's Bronzewing South tenement.
- Follow-up drilling will focus on depth and strike extensions to previously reported drill intercepts.
- Ken's Bore area shows potential with high-grade gold mineralisation associated with the boundary of the Hamster Granite.
- Hammer completed a comprehensive review of the Yandal Projects generating promising gold targets.
- The upcoming drilling program is scheduled before the end of the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Air New Zealand Limited (AIZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,792 |
Notice of share buyback
|
1 May 2025 8:55AM |
$0.535 |
$0.540 |
risen by
0.93%
|
|
| Venus Metals Corporation Limited (VMC) ORDINARY FULLY PAID |
Materials |
$23 |
Sandstone Gold Project CSIRO Kick-Start Program Funding
|
1 May 2025 8:55AM |
$0.102 |
$0.115 |
risen by
13.30%
|
|
VMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Venus Metals Corporation collaborates with CSIRO for Sandstone Gold Project.
- Project funded through the CSIRO Kick-Start Program.
- Funding amount is $47,426.
- Research to enhance mineral exploration using hyperspectral imaging.
- Project duration is expected to be six months.
- Aim is to improve targeting of gold and copper mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,630 |
Update - Notification of buy-back - NEU
|
1 May 2025 8:53AM |
$11.660 |
$13.100 |
risen by
12.35%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$68 |
Quarterly Investor Presentation April 2025
|
1 May 2025 8:49AM |
$0.035 |
$0.037 |
risen by
5.71%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,042 |
Update - Notification of buy-back - AOV
|
1 May 2025 8:49AM |
$7.760 |
$7.670 |
fallen by
1.16%
|
|
| AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$27 |
Final Director's Interest Notice
|
1 May 2025 8:46AM |
$0.007 |
$0.010 |
risen by
42.86%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,456 |
Update - Notification of buy-back - ZIP
|
1 May 2025 8:46AM |
$1.730 |
$2.670 |
risen by
54.34%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
